Initial Treatment Approach for Hyponatremia
The initial treatment of hyponatremia must be determined by symptom severity and volume status, with severe symptomatic patients requiring immediate 3% hypertonic saline to increase sodium by 6 mmol/L over 6 hours, while asymptomatic or mildly symptomatic patients should receive treatment based on their volume status—fluid restriction for euvolemic/hypervolemic states or isotonic saline for hypovolemic states—always limiting correction to a maximum of 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome. 1
Step 1: Assess Symptom Severity
Severe Symptomatic Hyponatremia (Medical Emergency)
- Severe symptoms include: seizures, coma, altered mental status, cardiorespiratory distress, or somnolence 1, 2
- Immediate treatment: Administer 3% hypertonic saline as 100-150 mL IV bolus over 10 minutes 1, 3
- Target correction: Increase sodium by 4-6 mmol/L over the first 6 hours or until severe symptoms resolve 1, 2
- Can repeat bolus: Up to three times at 10-minute intervals if symptoms persist 1
- Monitor sodium: Every 2 hours during initial correction 1
Mild to Moderate Symptoms
- Symptoms include: nausea, vomiting, headache, confusion, weakness 1, 2
- Treatment approach: Based on volume status (see Step 2) with less aggressive correction 1
- Monitor sodium: Every 4 hours initially, then daily 1
Asymptomatic Hyponatremia
- Treatment: Based entirely on volume status and underlying etiology 1
- Correction rate: More conservative, 4-6 mmol/L per day 1
Step 2: Determine Volume Status and Initial Workup
Essential initial tests: Serum and urine osmolality, urine sodium, urine electrolytes, serum uric acid, and clinical assessment of extracellular fluid volume 1
Hypovolemic Hyponatremia
- Clinical signs: Orthostatic hypotension, dry mucous membranes, decreased skin turgor, tachycardia 1
- Urine sodium: Typically <30 mmol/L (71-100% predictive of response to saline) 1
- Treatment: Discontinue diuretics immediately and administer 0.9% isotonic saline for volume repletion 1
- Avoid: Hypotonic fluids, which will worsen hyponatremia 1
Euvolemic Hyponatremia (SIADH)
- Clinical signs: No edema, no orthostatic hypotension, normal skin turgor, moist mucous membranes 1
- Urine sodium: >20-40 mmol/L with urine osmolality >300 mOsm/kg 1
- Serum uric acid: <4 mg/dL (73-100% predictive of SIADH) 1
- First-line treatment: Fluid restriction to 1 L/day 1, 2
- If no response: Add oral sodium chloride 100 mEq three times daily 1
- Second-line options: Urea or tolvaptan for resistant cases 1, 3, 2
Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)
- Clinical signs: Edema, ascites, jugular venous distention 1
- Treatment: Fluid restriction to 1-1.5 L/day for sodium <125 mmol/L 1
- Additional measures: Discontinue diuretics temporarily if sodium <125 mmol/L 1
- For cirrhosis: Consider albumin infusion alongside fluid restriction 1
- Avoid: Hypertonic saline unless life-threatening symptoms present, as it worsens edema and ascites 1
Step 3: Critical Correction Rate Limits
Maximum correction rates to prevent osmotic demyelination syndrome:
Standard Risk Patients
- Maximum: 8 mmol/L in 24 hours 1, 4, 2
- Preferred rate: 4-6 mmol/L per day 1
- Never exceed: 10-12 mmol/L in 24 hours 1, 4
High-Risk Patients (Require More Cautious Correction)
- Risk factors: Advanced liver disease, alcoholism, malnutrition, severe hyponatremia, prior encephalopathy 1, 4
- Maximum: 4-6 mmol/L per day, not exceeding 8 mmol/L in 24 hours 1
- Liver transplant recipients: Risk of osmotic demyelination is 0.5-1.5% 1
Monitoring During Correction
- Severe symptoms: Check sodium every 2 hours during initial correction 1
- After symptom resolution: Check every 4 hours 1
- Chronic hyponatremia: Daily monitoring to ensure correction doesn't exceed limits 1
Step 4: Special Considerations and Common Pitfalls
Neurosurgical Patients (Critical Distinction)
- Cerebral salt wasting (CSW) vs SIADH: Treatment approaches differ fundamentally 1
- CSW treatment: Volume and sodium replacement with isotonic or hypertonic saline, plus fludrocortisone 1
- CSW warning: Fluid restriction worsens outcomes—never restrict fluids in CSW 1
- Subarachnoid hemorrhage: Avoid fluid restriction in patients at risk for vasospasm 1
Pharmacological Options for Resistant Cases
Tolvaptan (Vasopressin Receptor Antagonist):
- FDA indication: Euvolemic or hypervolemic hyponatremia with sodium <125 mEq/L or symptomatic hyponatremia resistant to fluid restriction 4
- Starting dose: 15 mg once daily, can titrate to 30 mg then 60 mg after at least 24 hours 4
- Hospital requirement: Must initiate and re-initiate in hospital with close sodium monitoring 4
- Maximum duration: 30 days to minimize liver injury risk 4
- Avoid fluid restriction: During first 24 hours of tolvaptan therapy 4
- Contraindications: Hypovolemic hyponatremia, inability to sense thirst, strong CYP3A inhibitors, anuria 4
- Cirrhosis caution: Higher risk of gastrointestinal bleeding (10% vs 2% placebo) 1
Urea:
- Dosing: 40 g in 100-150 mL normal saline every 8 hours for 1-2 days in neurosurgical patients 1
- Advantages: Very effective and safe for SIADH 3, 2
- Note: Home preparation with table salt not recommended due to formulation errors 1
Managing Overcorrection
If overcorrection occurs (>8 mmol/L in 24 hours):
- Immediately: Discontinue current fluids and switch to D5W (5% dextrose in water) 1
- Consider: Desmopressin to slow or reverse rapid sodium rise 1
- Goal: Bring total 24-hour correction to no more than 8 mmol/L from starting point 1
- Watch for osmotic demyelination: Dysarthria, dysphagia, oculomotor dysfunction, quadriparesis typically 2-7 days after rapid correction 1, 4
Common Pitfalls to Avoid
- Using normal saline in SIADH: Will worsen hyponatremia; use fluid restriction instead 1
- Fluid restriction in CSW: Worsens outcomes; requires volume replacement 1
- Ignoring mild hyponatremia (130-135 mmol/L): Even mild hyponatremia increases fall risk (21% vs 5%) and is associated with cognitive impairment 1, 2
- Hypertonic saline in hypervolemic states: Worsens edema and ascites unless life-threatening symptoms 1
- Inadequate monitoring: Failure to check sodium frequently enough during active correction 1
- Failing to identify underlying cause: Always treat the root cause alongside sodium correction 1